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Abstract 
Abstract of thesis entitled: Exhaled Nitric Oxide in Chinese Schoolchildren 
Submitted by LIU Kin Hang 
for the degree of Master of Philosophy in Medical Sciences 
at The Chinese University of Hong Kong in August 2005 
Exhaled nitric oxide (eNO) has been found to be increased in patients with 
inflammatory pulmonary disease such as asthma and it could serve as a noninvasive 
marker of airway inflammation. Monitoring of the level may help doctors to adjust 
the dosage of anti-inflammatory therapy. Exhaled NO levels vary greatly 
depending on the extent of the airway inflammation and the treatment used. Levels 
are increased in individuals experiencing asthmatic exacerbation and are lower in 
patients with stable asthma receiving anti-inflammatory treatment. Therefore, the 
use of standardized methodology of eNO measurement and the establishment of a 
reference range for eNO level will make both monitoring and treatment of asthma 
more reliable. Since data on reference normal level of eNO is limited, a study with 
a large sample of schoolchildren would potentially reveal important insights into the 
I 
^ possible influence of gender and anthropometric measurements on the level of eNO. 
i 
The levels of exhaled NO were determined in a large number of schoolchildren 
recruited randomly from secondary schools distributed throughout Hong Kong 
aiming at determining the eNO levels among normal control children as well as 
children with other atopic disorders. In our paediatric asthma clinics, a group of 
asthmatic patients without corticosteroid treatment and recent upper respiratory tract 
infection were also recruited for comparison. Exhaled NO levels were measured by 
standardized methodology using a FDA approved instrument, NIOX® (Aerocrine AB, 
Stockholm, Sweden), according to ATS/ERS guideline. 
Among the normal control children, there were no significant correlations 
between exhaled NO level and anthropometric measurements such as height, weight, 
body mass index (BMI) and body surface area (BSA). 
Exhaled NO can be used in epidemiologic studies as a noninvasive marker of 
allergic airway inflammation in schoolchildren. The results demonstrated 
significant difference of the eNO level between boys and girls. In addition to 
gender, there may be other determinants of eNO levels such as genetic variations. 
Our data also demonstrated that allergic disorders such as allergic rhinitis and 
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Section I: Overview  
1.1 Asthma and Assessment of Airway Inflammation 
Asthma is one of the most common chronic disorders in children, and its 
prevalence varies widely in different regions of the world (ISAAC Steering 
Committee, 1998). Recent epidemiological studies suggested that the prevalence of 
asthma and allergic diseases is increasing in many Western and developing countries 
(Aberg et cd., 1995; Venn et al., 1998). The prevalence rate of asthma in children 
has been reported as high as 20-30 % in Australia and New Zealand. 
Asthma is a complex disease which is characterized by the following 
features 一 intermittent reversible airway obstruction, airway hyperresponsiveness, 
and airway inflammation as well as airway remodeling (Haley and Drazen, 1998). 
The most important pathogenic mechanism causing airway obstruction is airway 
inflammation. The cornerstone of current treatment of asthma is the use of 
anti-inflammatory drugs (GINA, 2004). However, there is no firm agreement as to 
I 
whether therapeutic intervention ought to be aimed at controlling symptoms alone, 
2 
optimizing lung function, or minimizing airway inflammation, and 
hyperresponsiveness (Crimi et al., 1998). 
The diagnosis and monitoring of asthma are primarily based on conventional 
measurements (British Thoracic Society, 2003), such as assessment of symptoms 
reported by the patient (history of wheeze, shortness of breath, and cough), 
measurements of airway obstruction by means of lung function study, assessment of 
bronchodilator response, and occasionally bronchial challenge tests to assess 
bronchial hyperresponsiveness (BHR). However, self-reporting of symptoms is 
much dependent on perception of symptoms with the potential for underestimation of 
the severity by the patients. 
International guidelines recommend the use of symptoms assessment and the 
measurement of serial peak expiratory flows or spirometry to classify the severity of 
asthma (GINA, 2004). The response to either inhaled bronchodilator or to a trial of 
corticosteroid is also included as part of current recommendations for the diagnosis 
of asthma. However, these traditional approaches would lead to some problems. 
First, lung function testings are primarily based on demonstrating abnormal airway 
,physiology. Particularly in mild asthma, lung function testing is often normal and 
3 
the results may not reflect the degree of airway inflammation (Hunter et al., 2002). 
1.1.1 Assessment of Airway Inflammation 
Asthma is a chronic inflammatory disorder characterized by the presence of 
inflammatory cells and the release of several inflammatory mediators in the airways. 
Assessment of airway inflammation may be useful for the diagnosis and monitoring 
of asthma (Shelhamer et aL, 1995). There are different invasive and noninvasive 
means for assessing airway inflammation. Clinical studies have suggested that 
monitoring these molecules might help to improve the control of asthma as they 
provide an objective marker for adjusting asthma medications (Smith et al., 2005). 
If the markers are to be used for the daily care of asthmatics, they should be 
relatively easy to obtain in both the primary care or referral settings. 
1.1.2 Invasive and Noninvasive Methods 
As inflammation is a central feature of asthma, measuring airway inflammation 
may be useful for the diagnosis and evaluation of asthma (Shelhamer et al., 1995). 
Until recently, only invasive techniques such as bronchoscopy can directly sample 
4 
bronchial tissue and fluids for the quantification of inflammatory cells and 
measurements of inflammatory mediators (Saetta et al, 1998; Heaney et al, 1996; 
Stevenson et al., 1997). In the last decade, there has been an increasing interest in 
the development of noninvasive techniques in assessing the extent of underlying 
airway inflammation and monitoring the efficacy of treatment (Little et al., 2000). 
Noninvasive monitoring of the effect of anti-inflammatory drugs in asthma 
would potentially be very useful as asthmatic patients may require a long period of 
anti-inflammatory therapy. One would like to use the lowest possible dose of such 
therapy (Wilson et al., 2002). Recently, a variety of noninvasive approaches, such 
as exhaled breath analysis (Kharitonov and Barnes, 2001) for inflammatory markers 
(exhaled gases and condensate) and sputum induction (Hargreave and Leigh, 1999) 
have been developed. These approaches allow clinicians to assess the degree of 
airway inflammation repeatedly. Examination of induced sputum is relatively 
noninvasive and produces valuable information on airway inflammation. However, 
induction of sputum can be difficult to use for day to day monitoring, as it provokes 
transient neutrophilia (Holz et al” 1998) and it may produce temporary decrements 
in lung function. Furthermore, the processing of sample is time-consuming, 
,expensive, and requires skilled technicians (Magnussen et al., 2000). The exhaled 
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breath condensate (EBC) approach is only in the early stage of development. The 
methodology needs to be standardized and validated before they can be used in the 
clinical setting. 
The measurement of exhaled nitric oxide (eNO) has attracted considerable 
interest, as it is simple, rapid and noninvasive for the assessment of airway 
inflammation (Lundberg et al, 1996). It can be performed repeatedly without 
causing undue discomfort for the patients. It can also be used in children, infants 
(Baraldi et cd., 1999b) and in patients with severe airflow obstruction, when other 
invasive methods are not possible or safe. Over the past decades, there have been 
many studies suggesting that eNO might be useful in assessing airway inflammation 
and its level correlated well with other markers of inflammation (Jatakanon et ai” 
1998b; Mattes et aL, 1999; Payne et aL, 2001; Warke et al., 2002). 
1.1.3 Exhaled Nitric Oxide as a Diagnostic Marker and Its 
Correlation with Other Markers of Inflammation 
Recent evidence suggests that eNO may be an excellent way to confirm or 
refute a diagnosis of asthma (Smith et aL, 2004). Exhaled nitric oxide has been 
6 
found to be the first marker to increase during asthma deterioration indicating that it 
may be used as a loss of control marker in asthma (Kharitonov et al., 1996a). 
Exhaled nitric oxide levels were increased prior to any significant changes in lung 
function, BHR, sputum eosinophilia or asthma symptoms. The deterioration of 
lung function is related to airway obstruction as a result of airway inflammation. 
Subclinical inflammation most likely precedes actual functional deterioration so that 
conventional lung function measures may deteriorate only after a period of ongoing 
airway inflammation. 
Exhaled nitric oxide has been validated against invasive measurements of 
airway inflammation such as biopsy findings obtained by bronchoscopy and induced 
sputum in asthma (Jatakanon et cd., 1998b; Mattes et al, 1999; Payne et al., 2001; 
Warke et al., 2002). The inflammatory origin of elevated levels of exhaled NO in 
asthma (Alving et al； 1993; Kharitonov et al, 1994; Persson et al” 1994), its 
responsiveness to suppression by corticosteroids (Kharitonov et al.，1996b) and its 
association with asthma severity may make measurement of exhaled NO an effective 
and practical marker to monitor the effect of anti-inflammatory treatment in asthma. 
( 
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1.1.4 Normal Reference Studies of Exhaled Nitric Oxide 
Exhaled nitric oxide may be very useful to guide diagnostic and therapeutic 
decisions in patients. In the past, the lack of standardization of eNO measurement 
has made it difficult to assess the clinical utility of eNO measurement. Previous 
studies on reference eNO values show that the range of eNO values varies widely 
among different studies (Dotsch et al., 1996; Silvestri et al., 1999; Latzin et al., 2002; 
Jouaville et al., 2003). It may be due to the use of different measurement 
conditions and techniques in each study (Latzin et al, 2002; Pedroletti et al, 2002). 
In addition, the sample sizes of these studies were too small to reveal any possible 
effects of gender and anthropometric measurements on the eNO values (Baraldi et al., 
1999a; Franklin et al, 1999). 
The normal reference range of exhaled NO levels has been reported to be 10 to 
20 ppb in nonatopic control adults (Kharitonov et al., 2003). Levels in patients with 
steroid-treated asthma are in the range of 30 to 40 ppb, whereas levels are often 
greater than 80 ppb in steroid-naive asthmatic patients (Silkoff et al., 2000). 
, There are no published studies large enough to provide accurate reference 
8 
values of eNO in children. The majority of the published studies of exhaled nitric 
oxide are from Caucasians (Baraldi et al, 1999a; Franklin et al, 1999; Jouaville et 
al” 2003). There has been a recent study of a small group of Japanese children (n = 
278) showing a slightly higher eNO values than in Caucasian children (Saito et al； 
2004). There have not been any systematic studies of eNO in Chinese children. 
Therefore, a reference study of the normal levels of eNO in Chinese is needed. As 
the production of endogenous NO is dependent on the level of the enzyme NO 
synthase (NOS) (Yates et a!., 1995), it is possible that differences in genetic 
background may affect the activity of this enzyme resulting in differences in eNO 
production (Wechsler et al., 2000; van's Gravesande et al., 2003). 
t 
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1.2 Aim of Study 
Traditionally, assessment of asthma is based on symptoms and simple lung 
function testing. Many of the objective markers of airway inflammation cannot be 
measured easily in a clinical setting. Exhaled NO potentially provides a very useful 
noninvasive marker for assessing airway inflammation in asthmatic patients. It is 
particularly useful in children as the procedure of measurement would not cause any 
discomfort. 
Therefore, the aims of the current study are: 
1) To establish the normal reference range of exhaled nitric oxide in the normal 
Chinese children. 
2) To assess the effects of gender and anthropometric measurements on the level of 
exhaled NO in Chinese schoolchildren. 
J 
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Section I: Overview  
如 I 
In order to establish the normal reference range of eNO in Chinese children, 
recruitment of a representative sample of normal children for the measurement of 
eNO is necessary. In Hong Kong, there are approximately 7,000,000 people with 
almost 20 % aged under 18 years. In order to establish the reference values of eNO 
for children, a random sample of normal control children needs to be recruited. 
There are approximately 400 secondary schools distributed in different districts of 
Hong Kong. A random sample of secondary schoolchildren can be recruited for 
participation in this survey. For comparisons, asthmatics identified in the school 
survey and patients from our paediatric asthma clinic will also be recruited for eNO 
measurement. 
In order to differentiate between normal controls and asthma in a population 
— study, a standardized and validated tool is needed. The International Study of 
Asthma and Allergies in Childhood (ISAAC) was designed to allow comparisons of 
asthma prevalence between populations in different countries (ISAAC Steering 
I 
" Committee, 1998). 
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ISAAC questionnaires consist of a written questionnaire and a video 
questionnaire. The use of the video one is to overcome the linguistic problems of 
interpretation of a written questionnaire. The translated ISAAC questionnaires have 
been validated among Hong Kong schoolchildren in predicting bronchial 
hyperresponsiveness (BHR) (Lai et aL, 1997). Therefore, ISAAC questionnaires 
can be employed for conducting population-based epidemiological study in order to 
identify whether the schoolchildren have asthma or not. 
Schoolchildren will be recruited for the measurement of eNO. They will 
complete the ISAAC questionnaires and they will be classified as asthmatic or not 
according to their responses to the questionnaire. A group of asthma patients 
followed up at the Prince of Wales Hospital will also be recruited for comparison. 
For the diagnosis of asthmatic patients from the hospital, the criteria established by 
the British Thoracic Society (BTS) will be used (British Thoracic Society, 1993). 
As the use of anti-inflammatory therapy was associated with reduction of eNO level 
(Baraldi et al.，1997; Kharitonov et aL, 1996b), only asthmatics who have not been 
on steroid for the previous three months will be recruited. 
I 
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Section II: Literature Review  
I 時 力 ^ ^ 狗 I  
3.1 Exhaled Nitric Oxide Production in Airway 
Nitric oxide (NO) is a simple molecule which unites neuroscience, physiology, 
and immunology, and revises scientists' understanding of how cells communicate and 
defend themselves. Nitric oxide has generated much interest in the field of science 
and it was crowned as “Molecule of the Year" in 1992 (Koshland, 1992). Nitric 
oxide was first found in the exhaled breath of human by Gustafsson et al. 
(Gustafsson et al” 1991). Inhibition of the enzyme nitric oxide synthase (NOS) 
would reduce the level of this gas in the exhaled air in guinea pigs and rabbits. In 
the respiratory tract, nitric oxide is produced by a wide variety of cell types including 
epithelial cells, airway nerves, inflammatory cells (macrophages, neutrophils, mast 
cells), and vascular endothelial cells (Kobzik et al” 1993; Hamid et al., 1993). 
I 
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3.2 Nitric Oxide Production and Function 
Nitric oxide serves as a key signaling molecule in physiological processes such 
as host defense, neuronal communication, and the regulation of vascular tone (Gross 
and Wolin, 1995; Liew and Cox, 1991). Although NO is an essential molecule, its 
production is not always beneficial. Nitric oxide has several key effects on airways. 
It is important for host defense and has toxic effect on microorganisms (bacteria or 
viruses). It may increase mucus secretion and act as potent vasodilator. Nitric 
oxide derived from airway epithelial cells may amplify asthmatic inflammation, by 
means of inhibition of T-helper 1 (Thl) cells and their production of interferon y 
(IFN-y) (Barnes and Liew, 1995). This would lead to an increase in the number of 
T-helper 2 (Th2) cells and increase the levels of cytokines such as IL-4 and IL-5. 
Once nasal contamination is controlled, several studies have established that NO 
in exhaled breath originates from the lower airways (Massaro et al” 1996) and is 
synthesized by NO synthases (NOSs). In normal controls, nitric oxide has been 
found to have a very high concentration in the paranasal sinuses (Alving et al.，1993; 
Kharitonov et al, 1996a). Nitric oxide levels are significantly increased in orally 
• exhaled air of patients with inflammatory airways disorders such as asthma, 
16 
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3.3 Nitric Oxide Synthase Pathway 
Nitric oxide is produced by a variety of cells via the nitric oxide synthase (NOS) 
pathway (Barnes and Belvisi, 1993). Nitric oxide synthase (NOS) is expressed in 
several cell types in the respiratory tract, including epithelial and vascular endothelial 
cells, macrophages, eosinophils and neurons (Kobzik et al, 1993; Hamid et al； 
1993). Nitric oxide in the exhaled air is produced in the epithelial cells of the 
bronchial wall. It is generated from the oxidation of guanidine nitrogen of 
L-arginine catalyzed by the enzyme NOS (Palmer et al., 1988; Moncada and Higgs, 
1993; Hemmens and Mayer, 1998). After the hydroxylation of the amino acid 
L-arginine to N°-hydroxy-L-arginine intermediate, nitric oxide is produced by 
oxidation of N^-hydroxy-L-arginine to L-citrulline. 
Nitric oxide synthase exists in several distinct isoforms, including neuronal 
NOS (nNOS or NOSl), inducible NOS (iNOS or N0S2) and endothelial NOS 
(eNOS or N0S3) (Nathan and Xie, 1994). NOSl and N0S3 were named neuronal 
NOS and endothelial NOS respectively because they were first discovered in the 
corresponding tissue, the nervous tissue and vascular endothelium (Lamas et al.， 
‘ 1992). Functionally, all of them can be classified into two major classes, 
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constitutive (cNOS) and inducible (iNOS) isoforms. All three types of NOS have 
been shown to be expressed in bronchial airways or nasal mucosa. Among them, 
two of which are constitutive (NOSl and N0S3) and the other one is inducible 
(N0S2). Constitutively expressed NOS is present largely in endothelial cells 
(eNOS) and neuronal tissue (nNOS) while inducible NOS (iNOS) is largely located 
in airway epithelial cells. In addition to neuronal, epithelial and endothelial cells, 
constitutively expressed NOS isoforms have been found in platelets (Bates and 
Silkoff, 2003). This constitutive form enzyme is calcium and 
calmodulin-dependent and releases picomolar levels of NO within seconds upon 
receptor stimulation by agonists such as acetylcholine and bradykinin (Berdeaux, 
1993). Activation of the enzyme in the neural tissue or endothelium will produce 
NO for the regulation of neurotransmission and vascular homeostasis. 
Inducible NOS (iNOS or N0S2) found in bronchial epithelium can be 
upregulated many times at sites of inflammation by mediators such as 
pro-inflammatory cytokines (Morris and Billiar, 1994). Once iNOS is activated, it 
can produce nanomolar level of NO and the increased production may continue for 
days (Robbins et al, 1994). This mechanism allows large amounts of NO to be 
.produced at sites of inflammation, thus reflecting the putative role of inducible NOS 
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in disease. In addition to bronchial epithelium, inducible NOS are found in several 
other cell types including hepatocytes and vascular smooth muscle cells. 
I 
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3.4 Factors Affecting Exhaled Nitric Oxide Level 
There are two approaches to measure eNO level in the expired air. They are 
the online and offline methods (American Thoracic Society, 1999). Online 
measurement is obtained in a single, flow-controlled exhalation against a resistance 
which can be easily performed by cooperative children and adults. On the other 
hand, offline measurement is using similar controlled exhalation during a single 
exhalation into the suitable collection reservoir which must be sealed for delayed 
analysis within a short period of time (Baraldi et al., 2002). 
Published eNO values for normal controls and asthmatic subjects vary widely 
among different studies (Baraldi et al” 1999a; Franklin et al, 1999; Jouaville et al, 
2003) as the values are highly depending on the measurement techniques (Latzin et 
al” 2002; Pedroletti et aL, 2002). For example, variations in sampling and breath 
acquisition techniques, mouth pressure and flow of the exhaled air, portion of flow 
profile taken as the prevailing eNO level (peak versus plateau values) can affect the 
results. Furthermore, mixing of NO originally produced in the paranasal sinuses 
and nasal cavity can contaminate the exhaled NO resulting in a much higher level 
,(Lundberg et al” 1994). Differences in measurement techniques make it very 
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difficult to compare results from different studies (Byrnes et ai, 1997; Silkoff et al., 
1997). 
Therefore, there is a need to standardize the measurement technique if eNO 
measurements are to be used in the clinical setting and for comparison of results 
from different laboratories. The factors leading to variation in measured eNO 
values can be grouped into procedure-related factors, patient factors and 
environmental factors. 
3.4.1 Procedure-related Factors 
3.4.1.1 Nasal Nitric Oxide Contamination 
It appears that the variation in eNO values has been largely due to nasal NO 
contamination (Lundberg et al., 1994) and variations in expiratory flows (Latzin et 
al., 2002). Nasal NO can accumulate to high concentrations relative to the level of 
NO in the lower respiratory tract. Since nasal NO can enter the posterior 
nasopharynx and contaminate the exhaled air, it is necessary to close the 
,velopharyngeal aperture in exhalation procedure in order to reduce the leakage of 
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nasal NO to a minimal level (Baraldi et aL, 2002). By maintaining the mouth 
pressure between 5-20 cm H2O during exhalation, it can ensure the closure of velum 
effectively thereby preventing nasal contamination. 
3.4.1.2 Exhalation Procedure — Starting Lung Volumes 
Exhaled NO values can also be influenced by starting lung volumes. Single 
breath exhalations are frequently performed from total or near-total lung capacity 
(Silkoff et al., 1997). At the same expiratory flow, the degree of lung expansion 
affects eNO values. Exhaled NO plateau values obtained with exhalations from the 
functional residual capacity (FRC) were significantly lower than those from total 
lung capacity (TLC) by almost 20 % (Baraldi et aL, 2002). Therefore, 
standardization of starting lung volume is important. 
3.4.1.3 Exhalation Procedure _ Flow 
The level of eNO is affected by exhalation flow or sampling flow while breath 
holding will lead to accumulation of NO in the airways (Silkoff et al., 1997). 
‘ Expiratory flow has been shown to have great effect on the eNO levels, with an 
23 
inverse relationship of eNO and expiratory flow. 
The probable reason for the reduction in NO concentration with increasing 
expiratory flow (Pedroletti et al., 2002) is that the same amount of NO produced by 
the airway epithelium will be dispersed in a large volume of expired air. Thus, with 




150-1 一 广 , , 為 “ - o - Controls 
i 
g 丨 0 0 - 1 
50- I v 
0 100 200 300 400 500 
Flow (ml/s) 
Figure 3.1: Exhaled FeNO at six different flows. The difference between 
groups was significant for FeNO at all flows (Pedroletti et al., 
‘ 2002). 
Studies have shown that children above eight years could achieve good and 
I 
- reproducible results (Silkoff et al., 2004). From a practical standpoint for children, 
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high exhalation flows cause a rapid decrease in lung volume before the desired 
pressure is reached (Pedroletti et al., 2002). It will be difficult for young children to 
maintain exhalation long enough to achieve a plateau. On the other hand, low flows 
may be impractical, because the exhalation period is too long before NO plateau can 
be achieved (Pedroletti et al, 2002). 
3.4.1.4 Circadian Rhythm 
It has been suggested that serial eNO measurement is better performed at the 
same time of the day as there might be variation of the eNO level in different time of 
the day. However, several studies have failed to confirm the relationship between 
the eNO value and the time of measurement recently (Georges et a/., 1999; ten 
Hacken et al, 1998; Latzin et al.’ 2002; Kharitonov et al., 2003). These studies did 
not show any significant circadian variation. Therefore, eNO can be measured at 
any time of the day. 
I 
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3.4.2 Patient Factors 
3.4.2.1 Sex 
A number of others factors unrelated to methodology may also affect the eNO 
levels. Tsang et al. has showed that eNO level is slightly higher in males than in 
females (Tsang et al., 2001). Other studies of children have been unable to confirm 
this relation but all these studies were relatively small (Latzin et al., 2002; Silvestri et 
al., 1999). Further studies with larger sample size are necessary to clarify the 
possible influence of gender on the eNO levels. 
3.4.2.2 Upper Respiratory Tract Infection 
The expression of iNOS can also be induced by viral infections in both upper 
and lower respiratory tract. This phenomenon occurs in normal and asthmatic 
individuals (Kharitonov et al.’ 1995; Alving et al., 1993). Therefore, it is important 
to take this factor into consideration when interpreting the results. 
( 
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3.4.2.3 Diet and Exhaled Nitric Oxide 
There has been a concern that nitrite in the saliva can be converted by 
nonenzymatic reaction to produce NO which may contribute to eNO level 
(Zetterquist et al” 1999). There are a variety of foods containing high levels of 
nitrate. After absorption in the gut, nitrate is actively transported from the blood to 
the salivary glands and excreted in the saliva (Tannenbaum et al., 1976). Some of 
the nitrate would undergo reduction to produce nitrite by anaerobic bacteria that 
colonize in the oral cavity (Zetterquist et al.，1999). This nitrite will then be 
converted to NO within the oral cavity. 
Nitrate is found in large amounts in many green vegetables like spinach and 
lettuce (Olin et al., 2001). There are not enough data in the literature to make any 
conclusion concerning how long patients should refrain from eating or drinking 
before eNO measurement. Elevation of eNO has been found after ingestion of 
nitrate or nitrate-containing foods (Zetterquist et al, 1999). Further studies are 
necessary to determine how diet can affect eNO level in normal controls or asthmatic 
subjects. 
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3.4.2.4 Effect of Spirometry and Exercise 
The effects of prior spirometry and exercise on subsequent eNO measurements 
have been studied. Tee and Hui investigated 106 asthmatic patients to determine if 
the eNO levels were different before and after a spirometry maneuver (Tee and Hui, 
2005). There was an insignificant decrease of the mean eNO by 2.2 ppb after 
spirometry. Gabriele et al. performed a study to investigate if exercise would affect 
the eNO levels. A total of 24 asthmatic children were studied (Gabriele et al” 
2005). They performed the eNO measurement before and 5, 15, 30, 45 and 60 
minutes after a 6-min walk test. There was a significant drop of mean eNO by 7.1 
ppb five minutes after exercise. Subsequently, the eNO levels returned to baseline 
within 30 minutes after exercise. Therefore, subjects should be resting for at least 
30 minutes prior to eNO measurement to avoid this potential confounding factor. 
3.4.3 Environmental Factors 
As environmental NO can reach high levels relative to those in exhaled breath 
(Baraldi et al., 1998), standardized techniques must prevent the contamination of 
,biological samples with ambient NO (American Thoracic Society, 1999). The 
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single-breath NO profile usually consists of an early peak and plateau. The early 
peak is due to nasal or ambient NO in the airways. Silkoff et al. found that nitric 
oxide concentration of inhaled gas in the order of 1000 ppb was associated with a 
huge early peak but had no effect on nitric oxide plateau (Silkoff et al., 1997). 
Inhaled NO is rapidly taken up by hemoglobin in pulmonary capillaries. Therefore, 
plateau values appear to be unaffected when the online method of measurement is 
used. However, if the exhaled gas is collected in a bag for analysis where dead 
spaces gas is included, exhaled NO values may vary depending on the ambient NO 
concentrations because of possible contamination. 
Adoption of a standardized measurement technique and establishment of a 
reference range in normal controls are crucial for the use of eNO measurement as a 
clinical tool. Recently, international investigators in the field of exhaled NO 
research from the American Thoracic Society (ATS) and the European Respiratory 
Society (ERS) have jointly developed a guideline for eNO measurement (American 
Thoracic Society, 2005). Furthermore, the NO monitoring system, NIOX® 
(Aerocrine AB, Stockholm, Sweden), is the first analyzer which has been approved 
by the US Food and Drug Administration (FDA) for clinical monitoring of NO in 
‘asthmatics (Silkoff et al., 2004). For meaningful comparisons between laboratories, 
2 9 
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Since the discovery of NO in the exhaled breath in 1991 (Gustafsson et al” 
1991), several studies have confirmed that exhaled NO is elevated in asthmatic 
patients when compared with those in normal controls (Alving et al., 1993; 
Kharitonov et al.’ 1994; Persson et al., 1994). Furthermore, exhaled NO has been 
confirmed to decrease with the use of corticosteroids in asthmatic patients 
(Kharitonov et al., 1996b). 
van Rensen et al. studied a group of 25 asthmatic adult patients aged 19-34 
years to determine the relationship of eNO and inhaled steroid treatment (van Rensen 
et al” 1999). The subjects studied were divided into two treatment groups either 
‘ using inhaled steroids or placebo twice-daily for four weeks. The markers of 
inflammation were monitored at weeks two and four of treatment, and two weeks 
after cessation of treatment. The results showed that exhaled NO level would 
decrease significantly during treatment period in the group taking inhaled 
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corticosteroid. In addition, the eNO level would increase back to the pretreatment 
level after washout for two weeks. These findings suggested that monitoring eNO 
may be an effective way to assess compliance with treatment. 
Inhaled corticosteroids 
epithelial 
l ^ H A ^ ^ l s A a i ^ t e J ^ ^ i ^ ^ i ^ l J l ^ J l ^ i ^ cells 
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Figure 4.1: Inhaled corticosteroids may inhibit transcription of several 
inflammatory genes in airway epithelial cells. 
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Section II: Literature Review 
Chapter of Exhaled Nitric 
5.1 Correlation of Findings from Biopsy and 
Bronchoalveolar Lavage with Exhaled Nitric Oxide 
In order to characterize and quantify the degree of airway inflammation, several 
invasive methods have been used and these include bronchoscopy with 
endobronchial biopsy (Saetta et al., 1998) and bronchoalveolar lavage (BAL) 
(Heaney et al” 1996; Stevenson et al.’ 1997). These methods are considered to be 
the most direct ways to assess the nature and the extent of airway inflammation 
(Fabbri et aL, 1998). However, repeated examination with these invasive methods 
may not be ethical or acceptable to the patients. In order to evaluate the accuracy of 
‘ NO measurement as a marker of eosinophilic inflammation indirectly in asthmatic 
patients, it is important to study the relationship between exhaled nitric oxide level 
and markers of airway inflammation obtained by these invasive means. 
I 
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Payne et al. performed a study to investigate the relationship between exhaled 
NO and the extent of eosinophilic inflammation obtained from biopsy samples of 
bronchial epithelium of asthmatic children (Payne et al.’ 2001). In their study, a 
total of 31 severe asthmatic children were recruited. Biopsy samples were 
processed with MBP immimostaining and assessed by point counting to determine 
the "eosinophil score" (Lim et al, 2000). There was a strong correlation (r = 0.67; 
P = 0.001) between the eNO level and eosinophil score of the biopsy specimens. 
The relationship between exhaled NO levels of asthmatic subjects and 
percentage eosinophils in BAL fluid has also been studied recently (Warke et al, 
2002). A total of 71 children admitted for elective surgical procedures were 
recruited for this study. Among them, 29 were asthmatics. BAL fluid obtained 
during the elective operations were processed for the eosinophil count. Again, a 
strong correlation between eNO and the percentage of BAL eosinophils was found (r 
=0.78; P < 0.001). 
I 
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5.2 Exhaled Nitric Oxide, Induced Sputum Analysis and 
Sputum Eosinophil Cationic Protein 
Eosinophilic inflammation in the airway correlates with the severity of 
bronchial asthma (Bousquet et al., 1990). The eosinophil counts and the amount of 
sputum eosinophil cationic protein (ECP) obtained from induced sputum increase in 
accordance with the severity of airway inflammation (Covar et al., 2004). By 
inhalation of hypertonic saline through an ultrasonic nebulizer, sputum could be 
induced successfully by the individuals (Pin et aL, 1992). Recently, sputum 
induction analysis was considered to be a noninvasive method to assess airway 
inflammation (Spanevello et al.’ 1995). The relation between exhaled NO and 
sputum eosinophils has been studied (Jatakanon et al., 1998b). The investigators 
recruited a total of 35 stable asthmatics for the measurement of eNO and sputum 
induction by hypertonic saline (3.5 %) inhalation. The results demonstrated a 
significant correlation (r = 0.48) between eNO and sputum eosinophils. Apart from 
counting the percentage of eosinophils in the induced sputum, sputum ECP can also 
be analyzed in the supernatants of the sputum plugs using radioimmunoassay (Covar 
et al., 2004). Exhaled NO has also been found to have a significant correlation with 
, spu tum ECP in a group of asthmatic children (Mattes et al, 1999). 
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In conclusion, there are very strong evidence that eNO is a reliable marker of 
airway inflammation as shown by its relationship with markers of airway 
inflammation obtained by either invasive or noninvasive means. 
I 
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Section III: Original Study 
I 
6.1 Study Population 
Schoolchildren aged 11-18 years were targeted for the study as part of the 
ISAAC Phase III study (ISAAC Steering Committee, 2000). A complete list of 
secondary schools was obtained from the Education and Manpower Bureau of the 
Government of the Hong Kong Special Administrative Region. Each school was 
individually allocated a number, and by computer randomization, a list of 30 schools 
was generated. Each school was invited to take part in the study down the order of 
the school list. Out of the first 15 schools contacted, a total of 12 schools agreed to 
participate and were able to provide 5,029 schoolchildren as potential subjects. 
These schools were distributed randomly throughout the three main regions of Hong 
Kong (Hong Kong Island, Kowloon and New Territories). The Ethics Committee 
‘ of the Chinese University of Hong Kong approved the study protocol, and the study 
was performed in the time between February and November 2004. Informed 
parental consent was distributed to parents or guardians beforehand and 4,320 agreed 
I 
to enroll their children in the study, representing a response rate of 86 %. 
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Generally, a class sized of 35-40 was assigned as a unit and a double-lesson 
period was given to each unit for the whole procedures to undertake. 
Schoolchildren with written agreements of parents or guardians were given a copy of 
questionnaire to complete. The questionnaire consisted of demographic questions 
in addition to ISAAC Phase III questionnaires. Since time was not allowed for 
every participant to perform the following assessments, only one-third of them were 
randomly recruited. Anthropometric characteristics such as height and weight were 
assessed for the selected participants followed by exhaled NO measurement. The 
subjects were asked not to eat for an hour prior to the measurements. 
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6.2 The International Study of Asthma and Allergies in 
Childhood 
The International Study of Asthma and Allergies in Childhood (ISAAC), was 
established in the early nineties to study the worldwide variation of asthma and 
related atopic disorders using standardized methodology (ISAAC Steering 
Committee, 1998). ISAAC developed from a merging of two multinational 
collaborative projects each investigating variations in childhood asthma at the 
population level. These were an initiative from Auckland, New Zealand to conduct 
an international comparative study of asthma severity, and an initiative from Bochum, 
Germany for an international study to monitor time trends and determinants of the 
prevalence of asthma and allergies in children. ISAAC is a unique project which 
has attracted worldwide interest and unprecedented large scale participation. 
ISAAC Phase One used simple methods for measuring the prevalence of childhood 
asthma, allergic rhinitis and atopic eczema for international comparisons. 
The ISAAC programme has allowed a worldwide assessment of the prevalence 
of self-reported symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema 
, i n children by standard methods (ISAAC Steering Committee, 1998). For many 
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collaborating centres, the ISAAC study was the first in their country to assess the 
epidemiology of these atopic diseases. The core questionnaires of the ISAAC 
protocol provide means to classify subjects with or without asthma in epidemiology 
studies. 
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6.3 ISAAC Questionnaires 
Each recruited subject was given an ISAAC Phase III written questionnaire to 
complete, followed by the video questionnaire at the same session in school 
(Appendix 1). Each subject was required to complete both questionnaires by 
themselves. The written questionnaire was translated into Chinese following the 
ISAAC protocol. This involved an independent person who was bilingual to 
translate the original English questionnaire into Chinese. Another bilingual person 
then back translated this into English for comparison in accordance with the 
guidelines laid down by the ISAAC Committee. The translated questionnaire was 
pilot tested and necessary modifications were made before the survey was carried 
out. 
All students completed the ISAAC questionnaires about wheezing, rhinitis and 
eczema. In addition, questions about recent health condition (e.g. fever, cold, upper 
respiratory tract infection) were asked for our reference. During the surveys at 
schools, written questionnaire was completed before the video questionnaire. The 
ISAAC written questionnaires asked for information on demography, symptoms of 
.wheeze , asthma, rhinitis and eczema. "Current" symptoms referred to symptoms in 
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the past 12 months; "asthma ever" was defined as having been diagnosed with 
asthma by a physician in the subject's lifetime. "Current asthma" was defined as 
having symptom of wheeze in the past 12 months in addition to having a diagnostic 
label of "asthma ever". "Rhinoconjunctivitis" was defined as sneezing or having a 
runny nose or blocked nose accompanied by itchy-watery eyes when the subject did 
not have an upper respiratory tract infection. "Eczema" was defined as an itchy 
rash which was coming and going for at least six months affecting the folds of 
elbows, behind the knees, in front of the ankles, under the buttocks or around the 
neck, ears or eyes. The ISAAC video questionnaire consisted of five scenes 
displaying young people of different ethnic origins with wheezing at rest, wheeze 
after exercise, night waking with wheeze, night waking with cough and severe 
asthma attack. After each sequence, students were asked if their breathing had ever 
been like that shown in the video and the frequency of such symptoms. There is 
another set of materials in English prepared for the students who are not familiar 
with the Chinese language (Appendix 2). The use of the video questionnaire is to 
overcome the translation problems associated with the written questionnaire as 
populations with different cultural and language background may have different 
interpretation of the written questions. 
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6.4 Standardized Approach for Answering Questions in the 
Field 
Some students would ask questions about their understanding of the questions 
during the survey conducted at the schools. The teachers were not allowed to 
explain the study protocol or the method of answering questions. Our research 
team would be responsible to answer the students' questions in a standardized way 
(ISAAC Steering Committee, 1998). The principles are shown as follows: 
1. Speak only to the individual who has the problem (identified by a raised 
hand). The first step is to read the written question out softly, exactly as it is 
written. 
2. If the student is still unable to answer the question, the next step is to 
encourage them to think about the meaning. 
3. If the student is still unable to answer the question, the next step is to give a 
little information without explaining the response required. 
4. If the student is still unable to answer the question, the last step is to state that 
if the student really does not know how to respond, they should leave the 
‘ question blank. 
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6.5 Anthropometric Measurements 
Anthropometric measurements are measures to examine subjects' body weight 
and size in routine clinical practice. It was safe and simple which could be applied 
easily in our school visits. Standing heights were measured by a portable 
standiometer. Weights were measured by Seca digital physician's scale. During 
height and weight measurements, subjects should be standing upright, arm resting by 
their side and without shoes but with socks on. In addition, any personal 
belongings including wallets, keys and outer clothing should be put down beforehand. 
By using height and weight obtained from each subject, body mass index (BMI) 
(Deurenberg et al., 1991) and body surface area (BSA) (Mosteller, 1987) were 








6.6 Exhaled Nitric Oxide Measurement 
6.6.1 NIOX® (Aerocrine AB, Stockholm, Sweden) 
NIOX® (Aerocrine AB，Stockholm, Sweden) is the first FDA approved Nitric 
Oxide Monitoring System (Silkoff et al., 2004) for routine clinical use in asthma 
patients. It measures nitric oxide (NO) in exhaled air according to ATS/ERS 
standard of eNO measurement (American Thoracic Society, 1999) and defined in 
parts per billion (ppb). It employs a chemiluminescence gas analyzer and integrated 
computer software to measure NO molecules at very low concentrations accurately. 
Based on the principal of chemiluminescence (Archer, 1993), NO in exhaled breath 
is drawn to a cooled reaction chamber and reacts with ozone as described follows: 
NO + Ozone — Nitrogen dioxide + Oxygen + Photon 
Upon the reaction shown above, nitrogen dioxide is formed under a 
photochemical reaction with the emission of photon which can be detected by a 
photomultiplier tube. The quantity of photon is proportional to the amount of NO 
in the exhaled breath sample. 
I 
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The NIOX® analyzer provides a single-breath online measurement of NO in a 
single exhalation with a measurement range of 2-200 ppb which is suitable for 
analysis. Despite the advanced technology employed, the instrument is relatively 
easy to use and is suitable not only for adults, but also for cooperative children 
(Baraldi et al., 2002). 
6.6.2 Calibration Procedures 
A daily calibration of the NIOX® instrument was not absolutely required unless 
it was moved or shut off. According to NIOX® analyzer manufacturer 
recommendation, regular calibration was usually performed every 14 days. 
However, if the environmental conditions were unstable, recalibration command was 
requested by the NIOX® instrument automatically in order to maintain a constant 
environment (e.g. stable temperature and humidity). Measurement of exhaled NO 
should not be continued until recalibration procedure was carried out properly. The 
NIOX® instrument was calibrated using standard NO calibration gas with known 
concentration which was manufactured by AG A Linde Healthcare. A two-point 
calibration was performed at 0 ppb and 200 ppb. After the zeroing procedure, the 
, h i g h calibration point was regulated by using the certified NO gas with guaranteed 
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concentration. A reference line was constructed in accordance with the calibration 
result each time. 
6.6.3 Exhaled Nitric Oxide Measurement 
Subjects first completed the ISAAC questionnaires and have been resting for at 
least 30 minutes prior to eNO measurement. Since the determination of eNO varies 
widely depending on the measuring techniques and conditions, exhaled NO was 
measured online using the NIOX® (Aerocrine AB, Stockholm, Sweden) according to 
the recommendation of the ATS/ERS guidelines (American Thoracic Society, 1999). 
Exhaled NO measurement was obtained with the subjects in the standing 
position. Subjects did not wear nose clips, and were instructed not to hold their 
breath before exhalation. Subjects were required to exhale to residual volume. In 
order to eliminate possible interference from ambient NO levels, subjects inhaled 
through an ambient air filter to total lung capacity and then exhale immediately for 
about ten seconds. In order to keep the soft palate closed for preventing nasal NO 
contamination, the column of collecting device has an internal restrictor that creates a 
, m o u t h pressure of 10-20 cm H2O during exhalation. The mouth pressure was 
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displayed on a screen instantaneously with the help of visual animation for the 
subjects to maintain a constant flow. At this mouth pressure, the expiratory flow 
would be kept constant at 50 ml/s. In the current study, NIOX® ambient air filter, 
which was able to filter against bacteria and virus, was employed. After each 
individual performance had completed, one's NIOX® filter should be disposed and 
subjected to replace with a new one for every new patient. Since environmental NO 
may sometimes be very high (> 100 ppb), inhalation of NO-free air through the 
NIOX® filter was preferable. At the same time, ambient air levels of NO were also 
measured by the NIOX® instrument automatically for each test which should be 
recorded immediately before assessing each new subject. 
The plateau value of exhaled NO was recorded automatically with the 
manufacturer's software. Participants repeated the maneuver after a minimum of 
30-second resting period until three consecutive acceptable tests with plateau values 
of exhaled NO were obtained. The ATS/ERS standard requires three eNO values 
varied less than 10 % (American Thoracic Society, 1999). The mean of these three 
readings was recorded as the exhaled NO level for a particular subject. Any 
exhalation which did not meet the standard requirements was not accepted by the 
,manufacturer 's software automatically and the subjects were asked to attempt 
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continuously until three acceptable readings were obtained. However, care should 
be taken in order not to make the subjects too exhausting if repeated measurements 
were required to perform. The maximum allowable number of exhalations per 
participant is eight according to the ATS/ERS standard (American Thoracic Society, 
1999). 
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6.7 Classification of Subjects 
Data from subjects who had symptoms of upper respiratory tract infection (URI) 
within the past two weeks were excluded as respiratory tract infection was known to 
affect eNO level (Kharitonov et al., 1995). The subjects were classified into three 
groups consisting of "normal controls", "allergic non-asthmatics" and "asthmatics". 
Those subjects who were not classified as anyone of the groups of "normal controls", 
"allergic non-asthmatic" or "asthmatics" but having symptom of wheezing ever only 
were grouped as "others". 
For those subjects who had never been diagnosed to have asthma and did not 
have any symptoms of wheeze, rhinitis or eczema in their lifetime according to the 
written and video questionnaires were classified as "normal controls". Subjects 
who had a physician diagnosis of asthma ever or current wheeze as documented by 
either written or video questionnaires were considered as "asthmatics". "Current 
asthma" was defined as having symptom of wheeze in the past 12 months in addition 
to having a diagnostic label of "asthma ever". The remaining subjects who did not 
\ 
have asthma and wheezing symptoms but had symptoms of rhinitis or eczema as 
, documen ted by the ISAAC questionnaires were categorized as “allergic 
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non-asthmatics". 
For comparison, another group of subjects with confirmed diagnosis of asthma 
according to the British Thoracic Society (BTS) criteria (British Thoracic Society, 
1993) was recruited for eNO measurement. They were recruited from the paediatric 
asthma clinic at the Prince of Wales Hospital (Hong Kong). These patients have not 
been taking anti-inflammatory treatment for three months prior to eNO measurement 
as the use of anti-inflammatory therapy was associated with reduction of eNO level 
(Kharitonov et al., 1996b). 
( 
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6.8 Statistical Analysis 
All data were entered into a computer twice by two independent persons. The 
data were categorized and analyzed using Statistical Package for Social Sciences 
(SPSS) for Windows Release 10.0 (SPSS Inc., Chicago, IL, USA). Exhaled NO 
levels in parts per billion (ppb) were presented as mean and median with 
inter-quartile range (IQR) unless otherwise stated. The eNO data was analyzed and 
was skewed to the right. The eNO values were therefore logarithmically 
transformed before analysis. Comparisons between groups were performed using 
Student's t test or Mann-Whitney [/-test. The correlation between eNO and 
anthropometric measurements, such as height, weight, body mass index (BMI), and 
body surface area (BSA), were determined by Spearman rank correlation test. All 
comparisons were made two-sided, and P-values less than 0.05 were considered 
significant. 
Furthermore, the influence of other atopic diseases such as rhinoconjunctivitis 
or eczema on eNO levels was also assessed by comparing the eNO level in children 
with and without these conditions. 
I 
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Section III: Original Study 
I — 々 — 及 咖 
7.1 Subjects and Demography 
A total of 4,320 schoolchildren completed the questionnaire survey as part of 
the International Study of Asthma and Allergies in Childhood (ISAAC) Phase III 
study. A random subgroup of 1,399 students was recruited for eNO measurement. 
Data from subjects who had symptoms of upper respiratory tract infection (URI) 
within the past two weeks were excluded as respiratory tract infection was known to 
affect eNO level (Kharitonov et al” 1995). Among the participating subjects 
without recent URI, 1,089 were Chinese and 165 were Caucasians. The other 106 
children were of other ethnic backgrounds such as Indian, Japanese, Korean, 
Malaysian or mixed ethnic background. 
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Subjects examined (n = 1,399; 738 males) 
Caucasians (n = 175; 97 males)  
Other ethnic groups (n = 111; 60 males) 
No URI (n = 165; 91 males)  
No URI (n = 106; 56 males) 
Chinese (n = 1,113; 581 males) 
Not successful (n = 1; 1 male) 
(unable to perform) 
Successful (n = 1,112; 580 males) 
URI (n = 23; 15 males) —— 
No URI (n = 1,089; 565 males) 
‘‘Others，，(n = 81;45 males) 
"Normal controls" "Allergic non-asthmatics” "Asthmatics" 
(n = 752; 368 males) (n = 197; 118 males) (n = 59; 34 males) 
Figure 7.1: Flow chart of subjects with eNO measurement. 
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The demographic characteristics of children who participated in the study are 
summarized in Table 7.1. There were a total of 752 Chinese (368 males) and 57 
Caucasian (25 males) controls. In addition, there were 59 Chinese asthmatics (34 
males) and 65 Caucasian asthmatics (43 males). There were 20 Chinese children 
(14 males) with "current asthma". A total of 106 subjects (56 males) were of the 
other ethnic backgrounds. The remaining 197 Chinese (118 males) and 23 
Caucasians (13 males) did not have asthma and wheezing symptoms but they had 
symptoms of rhinitis or eczema as documented by the ISAAC questionnaires. 
These subjects were categorized as "allergic non-asthmatic". Among 1,089 
Chinese without recent upper respiratory tract infection, 81 subjects who were not 
classified as anyone of the groups of "normal controls", "allergic non-asthmatic" or 




























































































































































































































































































































































































7.2 Exhaled Nitric Oxide in Chinese Children 
Since the distribution of exhaled nitric oxide levels of the population of normal 
controls was skewed to the right as shown in figure 7.2, logarithmic transformation 
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Figure 7.2: Histogram of levels of exhaled nitric oxide in the study population. 
The theoretical normal distribution is given by the line. 
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Figure 7.3: Histogram of log transformed levels of exhaled nitric oxide in the 
study population. 
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Figure 7.4: Box-plots showing median and inter-quartile ranges of exhaled 
nitric oxide (eNO) in Chinese controls. 
Y-axis is shown in log scale. 
Figure 7.4 shows the comparison of eNO levels in control Chinese children. 
The mean eNO (median; IQR) in males was 17.4 ppb (11.3; 7.6-20.9) while it was 
12.1 ppb (8.8; 5.9-12.8) in females. The eNO level was higher in males than in 
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Figure 7.5: Box-plots showing median and inter-quartile ranges of exhaled 
nitric oxide (eNO) in Chinese controls, allergic non-asthmatics and 
asthmatics. 
V 
Y-axis is shown in log scale. {* P < 0.001) 
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Figure 7.5 shows the comparison of eNO levels for Chinese controls, allergic 
non-asthmatics and asthmatics. For asthmatic males, the mean eNO (median; IQR) 
was 43.4 ppb (33.3; 12.0-56.0); for asthmatic females, 35.0 ppb (18.0; 10.5-51.1). 
For both males and females, the eNO levels of the asthmatics were higher than that 
of normal controls of the same sex {P < 0.001). The mean (median; IQR) eNO of 
Chinese children with "current asthma" (14 males and 6 females) was 56.0 ppb (47.1; 
29.1-67.5). 
For the allergic non-asthmatic Chinese males, the mean eNO (median; IQR) was 
27.6 ppb (19.0; 11.0-40.5); for females, 18.5 ppb (12.3; 8.7-25.4). The eNO level 
for this group of subjects was also higher in males than in females {P = 0.003). For 
both Chinese male and female, the eNO level of asthmatics was higher than that of 
allergic non-asthmatics {P = 0.048 and P = 0.027 respectively) as shown in figure 7.5. 
In addition, the eNO level of allergic non-asthmatics was also different from that of 
normal controls of the same sex (P < 0.001). 
( 
62 
300. " 蕭 
2 0 0 - ^ P< 0.001 
P < 0.001 ― ^ 
1 0 0 -
S 5 � - 45.5 47.2 
0 •g  
•>< 0 
_o 2 0 -
夸 15-
1 1 0 - — — ” . 3 r ^ � � 
ra o.o  




Controls Clinic Controls Clinic 
Asthmatics Asthmatics 
Male Female 
(n = 368) (n = 54) (n = 384) (n = 37) 
• Figure 7.6: Box-plots showing median and inter-quartile ranges of exhaled 
nitric oxide (eNO) in Chinese controls and clinic asthmatics. 





A total number of 91 asthmatics (54 males) were recruited from the asthma 
clinic for eNO measurement. The mean age (range) was 12.3 years (6-21). Figure 
7.6 shows the comparison of eNO levels for Chinese controls and clinic asthmatic 
subjects. The exhaled NO level was again significantly higher in subjects with 
asthma than in non-asthmatic normal controls. For asthmatic males, the mean eNO 
(median; IQR) was 52.0 ppb (45.5; 28.6-73.4); for asthmatic females, 52.3 ppb (47.2; 
32.4-70.0). For both males and females, the eNO levels of the asthmatics were 
higher than that of normal controls of the same sex {P < 0.001). These results are 
similar to those found in the asthmatic children recruited from schools. 
I 
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Table 12 shows the correlation between the eNO levels and the anthropometric 
measurements in Chinese normal controls. Exhaled NO levels did not show any 
significant correlation with height, weight, body mass index (BMI) or body surface 
area (BSA). 
Table 7.2: Correlation of exhaled nitric oxide level and anthropometric 
measurements in Chinese normal controls. 
Male Female Combined 
n = 368 n = 384 n = 752 
X P r P X P 
Height -0.086 0.098 -0.032 0.541 0.050 0.167 
Weight -0.049 0.346 0.018 0.727 0.043 0.242 
Body mass index 0.007 0.895 0.028 0.581 0.017 0.643 
Body surface area -0.057 0.279 0.013 0.800 0.050 0.168 
I 
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7.3 Exhaled Nitric Oxide in Caucasians and Other Ethnic 
Groups 
Table 7.3 shows the results of the current study compared with the population 
reference values reported in the literature. Chinese controls were found to have 
slightly higher eNO levels when compared with the levels of Caucasians reported in 
the literature (Dotsch et al.，1996; Silvestri et al, 1999; Baraldi et aL, 1999a; 
Franklin et al., 1999; Latzin et al., 2002; Jouaville et al., 2003). 
Table 7.3: Comparison of reference values of eNO in normal control children. 
Study (year) n Median age Mean eNO Expiratory flow 
(years) (ppb) (ml/s) 
Dotsch et al. (1996) 37 Not given 3.0 Not given 
Silvestri er al. (1999) 22 Not given 4.0 Not given 
Baraldi et al. (1999) 159 6-15 (range) 8.7 Not given 
Franklin et al. (1999) 157 9.7 (mean) 10.3 50 
Latzin et al. (2002) 63 12.2 11.9 45 
• Jouaville etal. (2003) 96 10.3 13 100 
Current study 
Chinese male 368 14.4 17.4 50 
Chinese female 384 14.4 \2A ^  
I 
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The eNO levels of Caucasians and other ethnic groups in the current study are 
summarized in table 7.4. For Caucasian male controls in our study, the mean eNO 
(median; IQR) was 14.1 ppb (12.5; 8.8-19.1); for Caucasian females, 14.6 ppb (10.7; 
6.0-13.5). Although the level was higher in males than in females, the difference 
did not reach statistical significance (P = 0.075). 
For the allergic non-asthmatic Caucasians (n = 23), their mean eNO (median; 
IQR) was 24.9 ppb (14.1; 9.5-38.2). The mean eNO (median; IQR) of asthmatic 
Caucasians (n = 65) was 32.9 ppb (15.8; 10.3-44.3). Their eNO were higher than 
the level of Caucasian controls (which were P = 0.023 and P < 0.001) respectively. 
We have also compared the eNO levels of Chinese and Caucasian controls. For 
both sexes, there was no significant difference between the levels in Chinese and 
Caucasians. 
For the control subjects of other Asian races (n = 24), their mean eNO (median; 
IQR) was 17.6 ppb (10.2; 8.6-25.0). Further subgroup analysis was not performed 
because of the small sample size. 
I 
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Table 7.4: Exhaled NO of normal controls in Caucasians and other Asian 
groups. 
Caucasians Other Asian groups 
Controls Controls 
n = 57 (25 males) n = 24 (14 males) 
Male 12.5 13.6 
(8.8-19.1) (8.9-30.9) 
Female 10.7 9.0 
(6.0-13.5) (7.9-13.1) 
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Asthma is a common condition affecting 10-30 % of children in developed 
countries. Despite the availability of effective therapeutic agents, many of the 
asthmatics continue to suffer significant morbidity related to sub-optimal treatment 
(Rabe et al.’ 2004). Although international guidelines recommend that treatment 
should be adjusted according to the level of severity reflected by the symptoms 
reported by patients along with lung function testing, many patients tend to 
underreport their symptoms resulting in underestimation of the severity by the 
physicians. 
Airway inflammation is one of the most important components of asthma. 
There are different methods to assess the degree of airway inflammation in asthmatic 
patients. Over the past decades, there have been a lot of research studies showing 
that exhaled nitric oxide may represent a useful noninvasive marker of airway 
inflammation. A recent prospective trial has also confirmed that the measurement 
of eNO might help the clinicians to use lower maintenance doses of inhaled steroid 
I 
in managing patients with persistent asthma (Smith et al., 2005). 
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In order to utilize exhaled nitric oxide measurement for the diagnosis and 
monitoring of asthma, normal reference range of eNO needs to be established. In 
the study of the current thesis, we aim at establishing the normal reference range of 
eNO in Chinese schoolchildren. In addition, we also determine the possible 
influence of gender and anthropometric measurements on the eNO levels. 
In this study with a large community sample of schoolchildren, a validated 
online monitoring system, NIOX® (Aerocrine AB, Stockholm, Sweden), was 
employed and measurements were made according to ATS and ERS guidelines. 
We have shown that the eNO level of normal controls is significantly higher in boys 
than in girls. In line with what has been published in the literature (Kharitonov et 
aL, 1994)，Chinese children with asthma or symptoms of wheeze had significantly 
higher eNO level than in controls. Furthermore, the results of the present study also 
confirm that there is a strong correlation between exhaled NO levels and symptoms 
of other allergic diseases such as rhinitis. 
This is one of the largest studies to investigate the eNO level in a community 
sample of schoolchildren. In Chinese children, the ISAAC questionnaires have 
, been validated against methacholine induced bronchial hyperresponsiveness (BHR) 
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(Lai et al., 1997). Having a physician diagnostic label of "asthma" had a sensitivity 
of 0.88 and a specificity of 0.90 in predicting asthma associated BHR. For the 
purpose of epidemiological study, the ISAAC questionnaires can be used for 
separating "asthmatics" from "normal controls". Many recent studies have 
demonstrated the potential of eNO measurement as a promising noninvasive marker 
for the diagnosis and assessment of asthma. Establishment of normal reference 
level is important for determining the utility of eNO measurement in different 
populations. Many research studies in the past decade were directed at 
investigating the relationship of eNO and other invasive markers of airway 
inflammation in asthmatics. Administration of oral or inhaled corticosteroids has 
been found to decrease eNO level in treated patients (Jatakanon et al.’ 1998a; Little 
et al., 2000). Silverstri et al. demonstrated that the eNO level was significantly 
related to the absolute number or percentage of blood eosinophils in asthmatic 
patients (Silvestri et al, 1999). Furthermore, Piacentini et al. has showed that FEVi 
has a significant inverse relationship with eNO level in asthmatic children (Piacentini 
et al., 2000). Exhaled NO level has also been found to have a significant 
relationship with serum eosinophil cationic protein (Strunk et al” 2003). Taken 
together, all these studies suggested that eNO level does reflect the degree of airway 
• inflammation and may be useful in asthma monitoring. Among the methods of 
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monitoring airway inflammation, only eNO measurement is a truly noninvasive 
method providing real-time results in the clinic setting. 
Although there have been a few population studies of the reference values of 
eNO in children, the sample sizes of these studies were too small to reveal the 
possible effects of gender and anthropometric measurements on the eNO levels 
(Latzin et al., 2002; Franklin et al, 2003; Jouaville et al., 2003). The current study 
clearly demonstrated a gender difference of eNO in Chinese schoolchildren. In the 
small group of Caucasian subjects in our study, we have also found a trend of higher 
eNO in males than in females but the difference did not reach statistical significance 
{P = 0.075). Further larger studies in Caucasians and other ethnic groups are 
needed to confirm whether such gender difference documented in the Chinese 
population is universal or not. The exact reasons for the possible gender differences 
are unknown. 
There are differences in the dimensional, structural, functional, immunological, 
hormonal characteristics and disease manifestations between the airways of male and 
female (Becklake and Kauffmann, 1999), and these differences may lead to varying 
, levels of eNO in males and females. The lungs of girls are generally smaller than 
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those of boys. One explanation for this gender difference could be that males have 
larger lung volumes including large expiratory dead space volumes relative body 
indices. Expiratory NO originates mainly in the dead space compartments and the 
size of this compartment may influence the total NO airway diffusing capacity, a 
factor that may influence the eNO level. Difference in flow within the intrathoracic 
airways may be one of the reasons for the gender difference. As the level of eNO is 
flow-dependent (lower eNO level with higher flow), to generate the same flow at the 
mouth level, the flow in the small airways should be higher in the girls as their 
airways are relatively smaller than those in the boys. As a result, the eNO 
concentration at the mouth level at a constant flow would be lower in females. 
Previous studies have demonstrated that atopic individuals have higher eNO 
level even when they do not have asthma or symptoms of wheeze (Franklin et al., 
2003; Jouaville et al, 2003). Data from a recent ISAAC study in Chinese 
schoolchildren showed that the prevalence of atopy as demonstrated by skin prick 
testing (SPT) was about 30 % which is similar to those reported in England and 
Australia (Wong et al., 2001). Difference in the rate of atopy among boys and girls 
may also be partly responsible for the gender difference. Dietary difference is 
, another possible reason affecting the eNO levels. Exhaled NO level has been found 
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to be significantly elevated after intake of a nitrate-rich meal (Olin et al., 2001). 
Nitrate is found to be present in relatively larger amounts in green vegetables such as 
lettuce and spinach. Studies of the possible food components in Chinese diet, 
which may affect the eNO level, are necessary. 
For the subjects of other Asian races in the current study, there were 24 control 
subjects (14 males) and their mean eNO was 17.6 ppb, which is comparable to the 
Chinese controls. The sample size of this group is rather small such that further 
subgroup analyses were not performed. Additional studies with larger sample of 
other Asian races are required to determine if their eNO levels are different from 
those of the Caucasians or Chinese. In addition, the eNO levels of the allergic 
non-asthmatic children in both Chinese and Caucasians were intermediate between 
the levels of the controls and asthmatics. The differences between the controls and 
their asthmatic counterparts were statistically significant in Chinese schoolchildren. 
Although there appears to be a big overlap of the eNO levels between normal 
controls and "asthmatics" in this study, one should note that the group of "asthmatic" 
children recruited from the schools included all those with a diagnostic label of 
asthma even if they did not have any current symptoms and some children (32 %) in 
, this category were on anti-inflammatory therapy. Therefore, a proportion of these 
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children might no longer have significant airway inflammation resulting in lower 
eNO levels. As shown in the figure 7.5，children with a physician's label of asthma 
along with symptom of wheeze within the past 12 months had the highest eNO level 
(median = 47.1 ppb). Measurement of a large group of confirmed asthmatic not on 
anti-inflammatory therapy will be necessary to fully assess the utility of eNO 
measurement as a diagnostic tool for asthma in children. 
I 
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Section III: Original Study  
Chapter 9: y^^oi^ipn and Further Studies | 
In order to improve asthma diagnosis and monitoring, a simple and reliable 
biomarker of airway inflammation is needed. Research studies in the past decade 
have confirmed that exhaled nitric oxide represents an accurate and reliable marker 
of airway inflammation. Exhaled NO levels correlate well with other known 
markers of airway inflammation obtained by invasive and noninvasive means. 
Clinical studies have confirmed that eNO predicts asthma exacerbations and its level 
will decrease with the use of anti-inflammatory therapy such as inhaled steroid. 
We have successfully recruited a large number of schoolchildren for the 
measurement of exhaled nitric oxide. We have demonstrated that eNO level is 
higher in boys than in girls. As reported in the literature, the eNO level was much 
higher in the asthmatics when compared with the normal controls. Children with 
‘ other allergic diseases will also have higher level of eNO even when they do not 
have asthma or wheeze. The results of our study have established the normal 
reference range of exhaled NO in Chinese boys and girls. We have also confirmed 
I 
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that anthropometric measures such as weight, height, BMI and body surface area do 
not have significant influences on the level of eNO. 
Several questions related to eNO remain unanswered. We have only tested a 
small group of Caucasian children and children of other Asian racial groups. Our 
sample did not have enough power to detect any gender difference of eNO within 
these racial groups. Studies with larger sample of these children are needed. The 
difference of eNO level between Chinese males and females is interesting although 
the exact reasons for the difference remain to be explored. This gender difference 
has important clinical implication because different cutoff levels should be used for 
males and females in the differentiation of asthmatics from normal controls. 
In order to maximize the participation rate of our study, we did not include skin 
prick testing (SPT) and blood testing for IgE measurements. As a result, we are not 
able to determine the relationship of atopy (as documented by SPT or serum IgE) and 
eNO level in our subjects. Further studies including these objective measures of 
atopy are needed to determine the influence of atopy on the eNO levels. 
� 
Furthermore, genetic studies of the NOS polymorphism are required to reveal their 
, possible influence on the eNO levels in different individuals (van's Gravesande et al” 
77 
2003; Wechsler et al, 2000; Wang et aL，2004). In addition, we should also extend 
our study to a younger age group in future studies to determine if children under 11 
years of age will have similar eNO levels when compared with the older children. 
Finally, measurements of the eNO levels in large groups of confirmed 
asthmatics including atopic and nonatopic asthma are needed to determine the 




Appendix 1 Questionnaires (Chinese Version) 






香 港 中 文 大 學 
醫 學 院 兒 科 學 系 




今天日期： 年 月 日 . 
學生姓名：（中文） (英文） 
年齡： 歲 出生日期： 年 月 日 





住址電話 ： 父親手提電話： 
母親’手提電話： 學生手提電話： 
請回答以下問題’並在適當的答案空格加上�Z�號。 
參過去2星期內，你有沒有上呼吸道感染 1 • 有 
“ (例如：傷風、感冒等症狀)？ 1 ~~I沒有 
醫生量度（學生不用塡寫） 檢查時間： 
身高： (厘米）體重： (千克）最近一餐進食時間： 
e N O ： A v g FeNo ： A v g V n o ：  
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請回答以下問題，並在適當的答案空格加上「7」號。 
1.你的胸部過往有沒有曾經發出 1 • 有 
喘聲、氣緊或He He聲？ 1 ~~|沒有 
【如果你的答案是「沒有」的話，請跳往問題（6)繼續作答。】 ^ 
2.過去12個月內，你的胸部有沒有發出 1 • 有 
喘聲、氣緊或He He聲？ 2 •沒有 
【如果你的答案是「沒有」的話’請跳往問題（6)繼續作答0】 • 
3.過去12個月內，你曾有過多少次氣緊？ 1 • 沒 有 
. • 1 - 3 次 





5.過去12個月內’你有沒有因爲氣喘到太嚴重 1 • 有 
而影響說話能力，每次吸氣只能講一至兩個字？ 2•沒有 
^ — — — 
6.你過往有沒有曾經透過醫生或醫院得知患上哮喘？ 1 • 有 
• 沒 有 
7.過去12個月內’你有沒有服用過任何 1 ~ ~ I有 
醫治氣喘（哮喘或氣管敏感)藥物？ 1 ~~ I沒有 
8.過去12個月內，你運動時或運動之後， 1 • 有 
胸部有沒有發出喘聲或咳嗽？ 2 •沒有 
-9.過去12個月內，除了患上傷風或肺部受感染的時候’ 1 • 有 








11.過去12個月內，你有沒有患有打晴晴、流鼻水或息塞間顆？ 1 ^ “ 
(注意：傷風或感冒的時候不計算在內) ~~ I沒有 
【如果你的答案是「沒有」的話，請跳往問題（14)繼續作答。】 • 
12.過去12個月內，上列鼻部不谪出現時， 1| I有 
你有沒有同時出現流眼水和眼睛痕癢的問題？ ~~ I沒有 
13.過去12個月內，上列鼻部不適怎樣影響你的日常生活？ 1|~I毫無影響 
. 2 • 些 微 影 響 
1 ~~I相當影響 
4•嚴重影響 
= ^ ,, 
14.你過往有沒有曾經透過醫生或醫院得知患上鼻敏感？ 1 ~ ~ I有 
2 •沒有 
15.你有沒有一些痕瘆持續半年或以上都未消散？ 1 ^""“ 
I沒有 
【如果你的答案是「沒有」的話，請跳往問題（20)繼續作答°】 
16.過去12個月內，這種痕疼有沒有發作？ 1 ^ “ 
2•沒有 
【如果你的答案是「沒有」的話’請跳往問題（20)繼續作答。】 ^ 
17. _痕疼有沒有影響以下身體部位：手时內側，膝頭後面， Q w 
腳躁前面，臀部下端，頸、耳朵或眼睛四周？ 2|~~I沒有 
18.過去12個月內，這種痕瘆有沒有完全消散？ 1|~~I有 





〜20.你過往有沒有曾經透過醫生或醫院得知患上濕瘆？ 1 • 有 






問題一：你在一生中，曾否出現過像片段中這種呼吸狀態？ 1 口 2|~~~ 
如果有：在去年出現過？ 1 口 2|~~ 
如果有：每月出現1次或多次？ 1 口 
片段二 ：片段二是兩個年輕人正在運動的情況。 
一個是穿深色衫，而另一個是穿淺色衫。 
問題二 ：你在一生中，曾否出現過像片段中穿深色衫的男孩 有 沒有 
那樣在運動時或運動後這種呼吸狀態？ 2 广 
如果有：在去年出現過？ 1 口 2 [ = 
如果有：每月出現1次或多次？ 1 口 2 [ 
片段三：片段三是一個年輕人在夜間醒過來的情況。 
有 沒有 
問題三：你在一生中，曾否出現過像片段中這樣在夜間醒過來？ 1 口 2 厂 
如果有：在去年出現過？ 1 口 2 匸 




如果有：在去年出現過？ 1 口 
如臬有：每月出現1次或多次？ 2 匸 
片段五：片段五是另外一個年輕人在靜止狀態下的情況。 
有 沒有 
‘問題五：你在一生中，曾否出現過像片段中這種呼吸狀態？ 2 「 
如果有：在去年出現過？ 1 口 2 [ = 
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Department of Paediatrics 
Faculty of Medicine 
The Chinese University of Hong Kong 
School Children Health Survey 2004 
Please tick “Z” or write your answers to these questions in the space 
provided. Most questions require you to tick “Z，，your answer in a box. 
If you make a mistake put a cross in the box and tick the correct answer. 
School: Class:  
Today's Date: / / 
Day Month Year 
Name: Age: 
Date of Birth: / / 
Day Month Year 
Sex: i| I 2| I Ethnicity/Race: ‘| [Chinese ^Non-Chinese 
Male Female J, 
Please specify:  
Place of Birth:  
• If you were not bom in Hong Kong, how many years have you lived in Hong Kong?  
yrs 
Home Address:  
Home Tel: Mom / Dad's Mobile:  
Please tick “Z” your answers to this question in the space provided. 
- • Have you had upper respiratory infection (e.g. symptoms 11 |Yes 
of cold or the flu) in the past 2 weeks? |NO 
Medical Officer Use Only Time:  
Height: (cm) Weight: (kg) Last Meal:  
eNO: Avg FeNo： AvgVNo：  
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Please tick “Z，，your answers to these questions in the 
space provided. 
1. Have you ever had wheezing or whistling |Yes 
in the chest at any time in the past? |NO 
� I F YOU HAVE ANSWERED “NO” PLEASE SKIP TO QUESTION 6 � ^ 
2. Have you had wheezing or whistling |Yes 
in the chest in the past 12 months? |NO 
� I F YOU HAVE ANSWERED “NO，，PLEASE SKIP TO QUESTION 6 � • 
3. How many attacks of wheezing ^ |None 
have you had in the past 12 months? 11 to 3 
'I to 12 
41 1 
I More than 12 
4. In the past 12 months, how often, on average, has ^ | [Never woken with wheezing 
your sleep been disturbed due to wheezing? [Less than one night per week 
31 1 
I One or more nights per week 
5. In the past 12 months, has wheezing ever been severe enough to limit your |Yes 
speech to only one or two words at a time between breaths? |NO 
^ — — — — 
6. Have you ever had asthma? M I Yes 
'I |NO 
7. Have you had taken any medications for |Yes 
asthma treatment in the past 12 months? |No 
8. In the past 12 months, has your chest |Yes 
sounded wheezy during or after exercise? |NO 
9. In the past 12 months, have you had a dry cough at night, |Yes 
apart from a cough associated with a cold or chest infection? |NO 
I 
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Questions 10-14 are about problems which occur when you DO NOT have 
a cold or the flu. 
10. Have you ever had a problem with sneezing, or a runny, |Yes 
2 I 
or blocked nose when you DID NOT have a cold or the flu? |No 
� I F YOU HAVE ANSWERED “NO，，PLEASE SKIP TO QUESTION 1 4 � ^ 
11. In the past 12 months, have you had a problem with sneezing, or a runny, ^ Yes 
or blocked nose when you DID NOT have a cold or the flu? |NO 
�I F YOU HAVE ANSWERED “NO，，PLEASE SKIP TO QUESTION 14 � • 
12. In the past 12 months, has this nose problem |Yes 
been accompanied by itchy-watery eyes? |NO 
13. In the past 12 months, how much did this nose i Not at all 
problem interfere with your daily activities? A little 
3| |A moderate amount 
• A lot 
^ V 
14. Have you ever had hay fever? i| |Yes 
'I |NO 
15. Have you ever had an itchy rash which was i Yes 
coming and going for at least six months? |NO 
� I F YOU HAVE ANSWERED “NO” PLEASE SKIP TO QUESTION 2 0 � ^ 
16. Have you had this itchy rash 11 |Yes 
at any time in the past 12 months? |NO 
� I F YOU HAVE ANSWERED “NO” PLEASE SKIP TO QUESTION 2 0 � ^ 
17. Has this itchy rash at any time affected any of the following places: |Yes 
the folds of the elbows, behind the knees, in front of the ankles, |NO 
under the buttocks, or around the neck, ears or eyes? 
18. Has this rash cleared completely i Yes 
. at any time during the past 12 months? ^ No 
19. In the past 12 months, how often, on average, have [Never in the past 12 months 
you been kept awake at night by this itchy rash? ^ Less than one night per week 
3| 1 
I One or more nights per week 
- 2 0 . Have you ever had eczema? i Yes 
' • N o 
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Video Questionnaire 
Please pay attention to the video and tick “v^ ，，your answers to these 
questions in the space provided. 
SCENE 1: The first scene is of a young person at rest. 
QUESTION 1: Has your breathing been like this, Yes No 
at any time in your life? 11 | 
if YES: has this happened in the past year? | 
� if YES: has this happened one or more times a month? i 2 
SCENE 2: The second scene is of two young people exercising. 
One is in a dark shirt and the other is in a white shirt. 
QUESTION 2: Has your breathing been like the boy's in the 
dark shirt during or following exercise Yes No 
at any time in your life? 1 2 
if YES: has this happened in the past year? | 
if YES: has this happened one or more times a month? 1 2 
SCENE 3: The third scene is of a young person waking at night. 
QUESTION 3: Have you been woken at night like this at Yes No 
any time in your life? 1 2 
if YES: has this happened in the past year? | 
if YES: has this happened one or more times a month? | 
SCENE 4: The fourth scene is also of a young person waking at night. 
QUESTION 4: Have you been woken at night like this at Yes No 
any time in your life? 11 ^ 
‘ i f YES: has this happened in the past year? | 
if YES: has this happened one or more times a month? | 
SCENE 5: The final scene is of another person at rest. 
QUESTION 5: . Has your breathing been like this, Yes No 
at any time in your life? 1 2 
� if YES: has this happened in the past year? | 
if YES: has this happened one or more times a month? | 
-The End-
***Thank you for taking part in this survey*** 
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